These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 14599020)
21. Synthesis and evaluation of substrate-mimicking cytosolic phospholipase A2 inhibitors--reducing the lipophilicity of the arachidonyl chain isostere. Walters I; Bennion C; Connolly S; Croshaw PJ; Hardy K; Hartopp P; Jackson CG; King SJ; Lawrence L; Mete A; Murray D; Robinson DH; Stein L; Wells E; John Withnall W Bioorg Med Chem Lett; 2004 Jul; 14(14):3645-9. PubMed ID: 15203135 [TBL] [Abstract][Full Text] [Related]
22. An efficient, stereocontrolled synthesis of a potent omuralide-salinosporin hybrid for selective proteasome inhibition. Reddy LR; Fournier JF; Subba Reddy BV; Corey EJ J Am Chem Soc; 2005 Jun; 127(25):8974-6. PubMed ID: 15969573 [TBL] [Abstract][Full Text] [Related]
23. A convergent approach toward the C1-C11 subunit of phoslactomycins and formal synthesis of phoslactomycin B. Druais V; Hall MJ; Corsi C; Wendeborn SV; Meyer C; Cossy J Org Lett; 2009 Feb; 11(4):935-8. PubMed ID: 19170620 [TBL] [Abstract][Full Text] [Related]
24. (E)-Phenyl- and -heteroaryl-substituted O-benzoyl-(or acyl)oximes as lipoprotein-associated phospholipase A2 inhibitors. Jeong TS; Kim MJ; Yu H; Kim KS; Choi JK; Kim SS; Lee WS Bioorg Med Chem Lett; 2005 Mar; 15(5):1525-7. PubMed ID: 15713421 [TBL] [Abstract][Full Text] [Related]
25. Potent inhibitors of secretory phospholipase A2: synthesis and inhibitory activities of indolizine and indene derivatives. Hagishita S; Yamada M; Shirahase K; Okada T; Murakami Y; Ito Y; Matsuura T; Wada M; Kato T; Ueno M; Chikazawa Y; Yamada K; Ono T; Teshirogi I; Ohtani M J Med Chem; 1996 Sep; 39(19):3636-58. PubMed ID: 8809154 [TBL] [Abstract][Full Text] [Related]
26. Competitive inhibition of lipolytic enzymes. III. Some acylamino analogues of phospholipids are potent competitive inhibitors of porcine pancreatic phospholipase A2. de Haas GH; Dijkman R; van Oort MG; Verger R Biochim Biophys Acta; 1990 Mar; 1043(1):75-82. PubMed ID: 2310763 [TBL] [Abstract][Full Text] [Related]
27. 3-(3,5-Dimethyl-4-octadecanoylpyrrol-2-yl)propionic acids as inhibitors of 85 kDa cytosolic phospholipase A2. Lehr M Arch Pharm (Weinheim); 1996 Nov; 329(11):483-8. PubMed ID: 8997897 [TBL] [Abstract][Full Text] [Related]
28. In silico-guided target identification of a scaffold-focused library: 1,3,5-triazepan-2,6-diones as novel phospholipase A2 inhibitors. Muller P; Lena G; Boilard E; Bezzine S; Lambeau G; Guichard G; Rognan D J Med Chem; 2006 Nov; 49(23):6768-78. PubMed ID: 17154507 [TBL] [Abstract][Full Text] [Related]
29. Lipidic mimetics as inhibitors of pancreatic phospholipase A2. Nicolaou A; Kokotos G; Constantinou V; York J; Gibbons WA Biochem Soc Trans; 1995 Nov; 23(4):614S. PubMed ID: 8654799 [No Abstract] [Full Text] [Related]
30. Sphingolactones: selective and irreversible inhibitors of neutral sphingomyelinase. Wascholowski V; Giannis A Angew Chem Int Ed Engl; 2006 Jan; 45(5):827-30. PubMed ID: 16365835 [No Abstract] [Full Text] [Related]
31. Inhibition of secretory phospholipase A2. 2-Synthesis and structure-activity relationship studies of 4,5-dihydro-3-(4-tetradecyloxybenzyl)-1,2,4-4H-oxadiazol-5-one (PMS1062) derivatives specific for group II enzyme. Dong CZ; Ahamada-Himidi A; Plocki S; Aoun D; Touaibia M; Meddad-Bel Habich N; Huet J; Redeuilh C; Ombetta JE; Godfroid JJ; Massicot F; Heymans F Bioorg Med Chem; 2005 Mar; 13(6):1989-2007. PubMed ID: 15727853 [TBL] [Abstract][Full Text] [Related]
32. Synthesis of lipidic amino acid and dipeptide inhibitors of human platelet phospholipase A2. Kokotos G; Constantinou-Kokotou V; Noula C; Nicolaou A; Gibbons WA Int J Pept Protein Res; 1996 Aug; 48(2):160-6. PubMed ID: 8872534 [TBL] [Abstract][Full Text] [Related]
33. [Synthesis of substituted benzoylacrylic acids as potential antagonists of phospholipase A2]. Nuhn P; Herrmann A; Radman M Pharmazie; 1999 Feb; 54(2):93-8. PubMed ID: 10084154 [TBL] [Abstract][Full Text] [Related]
34. Synthesis and phospholipase A2 inhibitory activity of thielocin B3 derivatives. Teshirogi I; Matsutani S; Shirahase K; Fujii Y; Yoshida T; Tanaka K; Ohtani M J Med Chem; 1996 Dec; 39(26):5183-91. PubMed ID: 8978846 [TBL] [Abstract][Full Text] [Related]
35. 1,2,4-Oxadiazolidin-3,5-diones and 1,3,5-triazin-2,4,6-triones as cytosolic phospholipase A2alpha inhibitors. Gopalsamy A; Yang H; Ellingboe JW; McKew JC; Tam S; Joseph-McCarthy D; Zhang W; Shen M; Clark JD Bioorg Med Chem Lett; 2006 Jun; 16(11):2978-81. PubMed ID: 16545564 [TBL] [Abstract][Full Text] [Related]
36. Structural elements of ligand recognition site in secretory phospho-lipase A2 and structure-based design of specific inhibitors. Singh N; Somvanshi RK; Sharma S; Dey S; Kaur P; Singh TP Curr Top Med Chem; 2007; 7(8):757-64. PubMed ID: 17456039 [TBL] [Abstract][Full Text] [Related]
37. 3-(Octadecanoylaminomethyl)indole-2-carboxylic acid derivatives and 1-methyl-3-octadecanoylindole-2-carboxylic acid as inhibitors of cytosolic phospholipase A2. Lehr M Arch Pharm (Weinheim); 1996; 329(8-9):386-92. PubMed ID: 8915098 [TBL] [Abstract][Full Text] [Related]
38. Lipid mimetics as inhibitors of human platelet phospholipase A2. Noula C; Constantinou V; Nicolaou A; Gibbons WA; Kokotos G Biochem Soc Trans; 1996 May; 24(2):303S. PubMed ID: 8736961 [No Abstract] [Full Text] [Related]
39. Total syntheses of (+)- and (-)-cacospongionolide B: new insight into structural requirements for phospholipase A(2) inhibition. Cheung AK; Snapper ML J Am Chem Soc; 2002 Oct; 124(39):11584-5. PubMed ID: 12296709 [TBL] [Abstract][Full Text] [Related]
40. Enantiospecific synthesis of the heparanase inhibitor (+)-trachyspic acid and stereoisomers from a common precursor. Zammit SC; Ferro V; Hammond E; Rizzacasa MA Org Biomol Chem; 2007 Sep; 5(17):2826-34. PubMed ID: 17700851 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]